Перейти к содержимому

OOS Investigation in Pharma: FDA Rules, Retesting, Root Cause & CAPA Explained

PharmaHealth Insights

0:00 / 0:00

OOS Investigation in Pharma: FDA Rules, Retesting, Root Cause & CAPA Explained

707 просмотров · 7 дней назад
PharmaHealth Insights
24 тыс. подписчиков
707 просмотров · 7 дней назад
What happens when a pharmaceutical batch fails an OOS test? This complete OOS Investigation in Pharma explains the FDA approach to Out of Specification results, laboratory investigation, retesting, resampling, root cause analysis and CAPA. In this detailed pharmaceutical OOS investigation masterclass, we walk through the complete OOS investigation process step by step — from the first failed laboratory result to laboratory investigation, manufacturing investigation, root cause determination, batch disposition and CAPA. An OOS result is much more than a failed test. It can raise critical questions about the laboratory, analyst, analytical method, sample preparation, instrument, system suitability, sampling, raw materials, manufacturing process, equipment and even other batches. And one of the most important questions is: Can you simply retest until you get a passing result? In this video, we explain why OOS investigations must be scientifically justified and why a passing retest does not automatically erase an original OOS result. WHAT YOU WILL LEARN 00:00 Introduction — Why OOS investigations matter • What is an OOS result? • OOS vs OOT • What should happen immediately after an OOS? • Phase 1 laboratory investigation • Checking analytical methods and calculations • Sample preparation errors • Reference standards and reagents • HPLC and instrument investigation • System suitability • Data integrity and original OOS results • Retesting vs resampling • Why "testing until you pass" is dangerous • Phase 2 manufacturing investigation • Batch manufacturing record review • Raw material and equipment investigation • Root cause analysis • Five Why's • CAPA • Impact on other batches • What happens when no root cause is identified? • Batch disposition • OOS vs OOT • Common mistakes in OOS investigations • Complete pharmaceutical industry example THE BIG QUESTION A good OOS investigation is not about proving that a batch should pass. It is about finding out what actually happened. Was the problem caused by the laboratory? The analyst? The instrument? The method? Sampling? Raw materials? Manufacturing? Equipment? Or was the batch genuinely out of specification? The answer must come from scientific evidence — not from the result we want to obtain. FDA OOS GUIDANCE This video discusses the principles described in the FDA's "Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production" guidance, including the revised May 2022 guidance. It also discusses the importance of thorough investigations, scientifically justified laboratory error conclusions, manufacturing investigations, root cause analysis and appropriate CAPA. WHO SHOULD WATCH THIS VIDEO? This video is especially useful for: • Pharmaceutical QA professionals • QC professionals • QC analysts • Quality Assurance Managers • Quality Control Managers • Production professionals • Manufacturing professionals • Regulatory Affairs professionals • Pharmaceutical auditors • GMP professionals • Validation professionals • Pharmacy students • M.Pharm / B.Pharm students • Pharmaceutical industry professionals preparing for interviews or audits Whether you are new to OOS investigations or already working in pharmaceutical quality, this video is designed to give you a practical understanding of how a strong OOS investigation should actually work. IMPORTANT TAKEAWAY Never investigate an OOS with the objective of making the result pass. Investigate it with the objective of finding the truth. Because in pharmaceutical manufacturing, a passing result is not enough. You need to understand WHY it passed — and WHY it failed when it failed. --- 📌 SUBSCRIBE TO PHARMAHEALTH INSIGHTS PharmaHealth Insights with Rajesh covers pharmaceutical quality, GMP, regulatory compliance, QA/QC, Revised Schedule M, FDA regulations, pharmaceutical manufacturing, audits, validation, pharma careers and practical industry knowledge. If you work in pharma or are preparing for a career in the pharmaceutical industry, subscribe and stay connected. #OOSInvestigation #PharmaQuality #GMP Get all Pharma and Healthcare content and tips at: Linkedin:   / pharmahealth-insights   Facebook:  / rajesh19733   Twitter: https://x.com/rajesh19733 Blog: https://rajeshkapoorpharma.blogspot.com WhatsApp: https://whatsapp.com/channel/0029Vavm... Mini website: https://deltacard.me/pharmahealthinsi... Website: https://sites.google.com/view/pharmah...